OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
CRISPR/CAS9: A promising approach for the research and treatment of cardiovascular diseases
Mengying Dong, Jian‐Gen Liu, Caixia Liu, et al.
Pharmacological Research (2022) Vol. 185, pp. 106480-106480
Closed Access | Times Cited: 13
Mengying Dong, Jian‐Gen Liu, Caixia Liu, et al.
Pharmacological Research (2022) Vol. 185, pp. 106480-106480
Closed Access | Times Cited: 13
Showing 13 citing articles:
Navigating the landscape of RNA delivery systems in cardiovascular disease therapeutics
Paula Gil-Cabrerizo, Teresa Simón‐Yarza, Elisa Garbayo, et al.
Advanced Drug Delivery Reviews (2024) Vol. 208, pp. 115302-115302
Open Access | Times Cited: 12
Paula Gil-Cabrerizo, Teresa Simón‐Yarza, Elisa Garbayo, et al.
Advanced Drug Delivery Reviews (2024) Vol. 208, pp. 115302-115302
Open Access | Times Cited: 12
Lipid nanoparticle (LNP) mediated mRNA delivery in cardiovascular diseases: Advances in genome editing and CAR T cell therapy
Setareh Soroudi, Mahmoud Reza Jaafari, Leila Arabi
Journal of Controlled Release (2024) Vol. 372, pp. 113-140
Closed Access | Times Cited: 10
Setareh Soroudi, Mahmoud Reza Jaafari, Leila Arabi
Journal of Controlled Release (2024) Vol. 372, pp. 113-140
Closed Access | Times Cited: 10
Emerging Trends and Innovations in the Treatment and Diagnosis of Atherosclerosis and Cardiovascular Disease: A Comprehensive Review towards Healthier Aging
Ibrahim Alradwan, Nojoud AL Fayez, Mohammad N. Alomary, et al.
Pharmaceutics (2024) Vol. 16, Iss. 8, pp. 1037-1037
Open Access | Times Cited: 6
Ibrahim Alradwan, Nojoud AL Fayez, Mohammad N. Alomary, et al.
Pharmaceutics (2024) Vol. 16, Iss. 8, pp. 1037-1037
Open Access | Times Cited: 6
Genome Editing Technology: A New Frontier for the Treatment and Prevention of Cardiovascular Diseases
Sumbul Saeed, Shahid Ullah Khan, Wasim Khan, et al.
Current Problems in Cardiology (2023) Vol. 48, Iss. 7, pp. 101692-101692
Open Access | Times Cited: 14
Sumbul Saeed, Shahid Ullah Khan, Wasim Khan, et al.
Current Problems in Cardiology (2023) Vol. 48, Iss. 7, pp. 101692-101692
Open Access | Times Cited: 14
Research progress and application of the CRISPR/Cas9 gene-editing technology based on hepatocellular carcinoma
Shijing Yu, Ruirui Zhao, Bingchen Zhang, et al.
Asian Journal of Pharmaceutical Sciences (2023) Vol. 18, Iss. 4, pp. 100828-100828
Open Access | Times Cited: 11
Shijing Yu, Ruirui Zhao, Bingchen Zhang, et al.
Asian Journal of Pharmaceutical Sciences (2023) Vol. 18, Iss. 4, pp. 100828-100828
Open Access | Times Cited: 11
Genetics of Aortic Aneurysm Disease: 10 Key Points for the Practitioner
John A. Elefteriades, Mohammad A. Zafar, Bulat A. Ziganshin
JTCVS Open (2024) Vol. 21, pp. 58-63
Open Access | Times Cited: 4
John A. Elefteriades, Mohammad A. Zafar, Bulat A. Ziganshin
JTCVS Open (2024) Vol. 21, pp. 58-63
Open Access | Times Cited: 4
Advancing Fish Disease Research through CRISPR-Cas Genome Editing: Recent Developments and Future Perspectives
Huria Marnis, Khairul Syahputra
Fish & Shellfish Immunology (2025), pp. 110220-110220
Closed Access
Huria Marnis, Khairul Syahputra
Fish & Shellfish Immunology (2025), pp. 110220-110220
Closed Access
Application of Advanced CRISPR/Cas-9 and Other Genomic Tools in RNA-Based Therapeutics
Tehreem Fatima Awan, Muhammad Jadoon Khan
(2025), pp. 15-33
Closed Access
Tehreem Fatima Awan, Muhammad Jadoon Khan
(2025), pp. 15-33
Closed Access
The key role of miRNA in syndromic and sporadic forms of ascending aortic aneurysms as biomarkers and targets of novel therapeutic strategies
Sonia Terriaca, Roberto Monastero, Augusto Orlandi, et al.
Frontiers in Genetics (2024) Vol. 15
Open Access | Times Cited: 2
Sonia Terriaca, Roberto Monastero, Augusto Orlandi, et al.
Frontiers in Genetics (2024) Vol. 15
Open Access | Times Cited: 2
Unravelling the impact of RNA methylation genetic and epigenetic machinery in the treatment of cardiomyopathy
Li Liu, Linxing Yu, Y Wang, et al.
Pharmacological Research (2024) Vol. 207, pp. 107305-107305
Open Access | Times Cited: 2
Li Liu, Linxing Yu, Y Wang, et al.
Pharmacological Research (2024) Vol. 207, pp. 107305-107305
Open Access | Times Cited: 2
Advancements in Omics and Breakthrough Gene Therapies: A Glimpse into the Future of Peripheral Artery Disease
Phillip G. Brennan, Lucas Mota, Tarek Aridi, et al.
Annals of Vascular Surgery (2024) Vol. 107, pp. 229-246
Closed Access | Times Cited: 1
Phillip G. Brennan, Lucas Mota, Tarek Aridi, et al.
Annals of Vascular Surgery (2024) Vol. 107, pp. 229-246
Closed Access | Times Cited: 1
Gene Therapy for Cardiovascular Disease: Clinical Perspectives
Young‐Shin Lee, Jung Ran Choi, Jin‐Bae Kim
Yonsei Medical Journal (2024) Vol. 65, Iss. 10, pp. 557-557
Open Access
Young‐Shin Lee, Jung Ran Choi, Jin‐Bae Kim
Yonsei Medical Journal (2024) Vol. 65, Iss. 10, pp. 557-557
Open Access
Pan-cancer analysis of m1A writer gene RRP8: implications for immune infiltration and prognosis in human cancers
Zhihui Huang, Koo Han Yoo, Duohui Li, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access
Zhihui Huang, Koo Han Yoo, Duohui Li, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access
